IN2014DN06121A - - Google Patents
Info
- Publication number
- IN2014DN06121A IN2014DN06121A IN6121DEN2014A IN2014DN06121A IN 2014DN06121 A IN2014DN06121 A IN 2014DN06121A IN 6121DEN2014 A IN6121DEN2014 A IN 6121DEN2014A IN 2014DN06121 A IN2014DN06121 A IN 2014DN06121A
- Authority
- IN
- India
- Prior art keywords
- ethyleneimine
- oligomer
- concentration
- aqueous solution
- range
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261592323P | 2012-01-30 | 2012-01-30 | |
| PCT/GB2013/050211 WO2013114112A2 (en) | 2012-01-30 | 2013-01-30 | Stabilized aqueous antibody compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06121A true IN2014DN06121A (pt) | 2015-08-14 |
Family
ID=47681959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6121DEN2014 IN2014DN06121A (pt) | 2012-01-30 | 2013-01-30 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10532098B2 (pt) |
| EP (1) | EP2809350B1 (pt) |
| JP (1) | JP2015506369A (pt) |
| CN (1) | CN104203282A (pt) |
| CA (1) | CA2861402C (pt) |
| DK (1) | DK2809350T3 (pt) |
| ES (1) | ES2705538T3 (pt) |
| IN (1) | IN2014DN06121A (pt) |
| WO (1) | WO2013114112A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2809350B1 (en) | 2012-01-30 | 2018-10-17 | Arecor Limited | Stabilized aqueous antibody compositions |
| AR107674A1 (es) * | 2016-02-19 | 2018-05-23 | Avery Dennison Corp | Método de dos etapas para procesamiento de adhesivos y composiciones relacionadas |
| GB201613896D0 (en) | 2016-08-12 | 2016-09-28 | Arecor Ltd | Novel composition |
| US11608357B2 (en) | 2018-08-28 | 2023-03-21 | Arecor Limited | Stabilized antibody protein solutions |
| EP3372241A1 (en) | 2017-03-06 | 2018-09-12 | Ares Trading S.A. | Liquid pharmaceutical composition |
| EP3372242A1 (en) | 2017-03-06 | 2018-09-12 | Ares Trading S.A. | Liquid pharmaceutical composition |
| JP2022500376A (ja) * | 2018-09-10 | 2022-01-04 | ダウ グローバル テクノロジーズ エルエルシー | タンパク質及びポリアルコキシ脂肪酸アシル界面活性剤を含む組成物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| US5990237A (en) | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
| DE19726186A1 (de) | 1997-06-20 | 1998-12-24 | Boehringer Ingelheim Int | Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen |
| DE19933024C2 (de) | 1999-07-15 | 2003-03-13 | Medinnova Ges Med Innovationen | Kationische Blockcopolymere |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| US7524938B2 (en) * | 2003-04-04 | 2009-04-28 | Yeda Research And Development Co., Ltd. | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| AU2004260935A1 (en) | 2003-06-30 | 2005-02-10 | Canji, Inc. | Polymer encapsulation of adenoviruses |
| US7022214B2 (en) * | 2004-01-21 | 2006-04-04 | Bio-Rad Laboratories, Inc. | Carrier ampholytes of high pH range |
| CA2600836A1 (en) | 2005-03-08 | 2006-09-14 | Pharmacia & Upjohn Company Llc | Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent |
| US20090011004A1 (en) | 2005-12-30 | 2009-01-08 | Philadelphia Health & Education Corp., D/B/A/ Drexel University Of College Of Medicine | Improved carriers for delivery of nucleic acid agents to cells and tissues |
| GB0700523D0 (en) | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
| US20080312174A1 (en) | 2007-06-05 | 2008-12-18 | Nitto Denko Corporation | Water soluble crosslinked polymers |
| CN102164943A (zh) | 2008-09-24 | 2011-08-24 | 稳定技术有限公司 | 使用糖和聚乙烯亚胺保存多肽的方法 |
| WO2010062896A1 (en) * | 2008-11-28 | 2010-06-03 | Abbott Laboratories | Stable antibody compositions and methods for stabilizing same |
| CN102946858B (zh) | 2010-05-10 | 2015-09-30 | 英塔斯制药有限公司 | 含有免疫球蛋白Fc的多肽的液体制剂 |
| US20130209465A1 (en) * | 2010-07-30 | 2013-08-15 | Arecor Ltd. | Stabilized Aqueous Antibody Compositions |
| EP2809350B1 (en) | 2012-01-30 | 2018-10-17 | Arecor Limited | Stabilized aqueous antibody compositions |
-
2013
- 2013-01-30 EP EP13703468.2A patent/EP2809350B1/en active Active
- 2013-01-30 US US14/375,257 patent/US10532098B2/en active Active
- 2013-01-30 JP JP2014553812A patent/JP2015506369A/ja active Pending
- 2013-01-30 CA CA2861402A patent/CA2861402C/en active Active
- 2013-01-30 ES ES13703468T patent/ES2705538T3/es active Active
- 2013-01-30 CN CN201380017932.0A patent/CN104203282A/zh active Pending
- 2013-01-30 DK DK13703468.2T patent/DK2809350T3/en active
- 2013-01-30 IN IN6121DEN2014 patent/IN2014DN06121A/en unknown
- 2013-01-30 WO PCT/GB2013/050211 patent/WO2013114112A2/en active Application Filing
-
2019
- 2019-11-27 US US16/697,999 patent/US20200138946A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2809350A2 (en) | 2014-12-10 |
| CN104203282A (zh) | 2014-12-10 |
| ES2705538T3 (es) | 2019-03-25 |
| CA2861402C (en) | 2021-10-12 |
| WO2013114112A3 (en) | 2013-11-07 |
| US10532098B2 (en) | 2020-01-14 |
| WO2013114112A2 (en) | 2013-08-08 |
| US20150010548A1 (en) | 2015-01-08 |
| DK2809350T3 (en) | 2019-01-28 |
| JP2015506369A (ja) | 2015-03-02 |
| EP2809350B1 (en) | 2018-10-17 |
| US20200138946A1 (en) | 2020-05-07 |
| CA2861402A1 (en) | 2013-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN06121A (pt) | ||
| NZ743964A (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| EA201890006A1 (ru) | Применение экзосом для лечения болезни | |
| CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
| EA201500314A1 (ru) | Лекарственные формы энзалутамида | |
| TN2015000050A1 (en) | Methods of treating a tauopathy | |
| EA201790378A1 (ru) | Заключенное в липосому аффинное лекарственное средство | |
| EA201491447A1 (ru) | Ендиины, их конъюгаты и способы их получения и применения | |
| EA201391416A1 (ru) | Новые соединения в качестве модуляторов протеинкиназ | |
| EA201590174A1 (ru) | Иммуноконъюгаты, содержащие анти-cd22 антитела | |
| EA201300987A1 (ru) | Фармацевтические композиции, включающие метформин и ингибитор dpp-4 или ингибитор sglt-2 | |
| MY160552A (en) | Low protein infant formula with increased essential amino acids | |
| AU343235S (en) | Bottle | |
| UA110470C2 (ru) | Антидот антикоагулянта | |
| AU339376S (en) | Sterilizing case | |
| AU344326S (en) | Bottle | |
| AU337524S (en) | Bottle | |
| GB2496342A (en) | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia | |
| TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
| MY173304A (en) | Induction of immune tolerance using methotrexate | |
| AU345141S (en) | Bottle | |
| ECSP15002095A (es) | Formulación farmacéutica | |
| EA201401117A1 (ru) | Композиции, содержащие пробиотики и комплекс пчелиной пыльцы/глины, способ их приготовления и их применение в питании и терапии | |
| AU343226S (en) | Bottle | |
| GT201300058A (es) | Composiciones de anticuerpos anti-vegfr-3 |